Wei Lv

523 total citations · 1 hit paper
14 papers, 381 citations indexed

About

Wei Lv is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Wei Lv has authored 14 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Organic Chemistry. Recurrent topics in Wei Lv's work include RNA modifications and cancer (3 papers), CRISPR and Genetic Engineering (3 papers) and DNA Repair Mechanisms (2 papers). Wei Lv is often cited by papers focused on RNA modifications and cancer (3 papers), CRISPR and Genetic Engineering (3 papers) and DNA Repair Mechanisms (2 papers). Wei Lv collaborates with scholars based in China, United States and Saint Kitts and Nevis. Wei Lv's co-authors include Alan P. Kozikowski, Brian Budke, Philip P. Connell, Huihui Wang, Yuanhong Xu, Tao Li, Lianzi Wang, Shubing Zhang, Xuemei Li and Shanshan Wang and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Journal of Medicinal Chemistry.

In The Last Decade

Wei Lv

13 papers receiving 376 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dynamic regulation and functions of mRNA m6A modification

2022 139 citations Shanshan Wang, Wei Lv et al. Cancer Cell International profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wei Lv China	9	307	82	71	58	29	14	381
Miao Zhong China	11	218 0.7×	93 1.1×	36 0.5×	44 0.8×	21 0.7×	20	379
Meng Cao China	11	340 1.1×	148 1.8×	57 0.8×	32 0.6×	6 0.2×	27	449
Jun Fujimoto Japan	10	217 0.7×	27 0.3×	27 0.4×	81 1.4×	13 0.4×	11	333
Vinod Tiwari United States	9	251 0.8×	41 0.5×	40 0.6×	45 0.8×	16 0.6×	15	374
Lewis E. Pennicott United Kingdom	7	319 1.0×	22 0.3×	222 3.1×	48 0.8×	23 0.8×	13	399
Harshal Khanwalkar France	12	212 0.7×	22 0.3×	56 0.8×	105 1.8×	21 0.7×	14	346
Anjie Xia China	9	237 0.8×	43 0.5×	22 0.3×	135 2.3×	49 1.7×	26	404
Vesna Markovic United States	10	128 0.4×	40 0.5×	40 0.6×	49 0.8×	7 0.2×	20	272
Xiaodong Hao China	11	185 0.6×	97 1.2×	70 1.0×	38 0.7×	4 0.1×	19	327
Tianyao Guo China	10	171 0.6×	56 0.7×	26 0.4×	15 0.3×	17 0.6×	14	280

Countries citing papers authored by Wei Lv

Since Specialization

Citations

This map shows the geographic impact of Wei Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Lv more than expected).

Fields of papers citing papers by Wei Lv

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Lv. The network helps show where Wei Lv may publish in the future.

Co-authorship network of co-authors of Wei Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Lv. A scholar is included among the top collaborators of Wei Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Lv. Wei Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Li, Conghui, Wei Lv, Zhiwei He, et al.. (2025). Landscape of A-I RNA editing in mouse, pig, macaque, and human brains. Nucleic Acids Research. 53(11).

Zhang, Yigan, Yanbin Dong, Shuwen Chen, et al.. (2023). Emerging roles of RNA ac4C modification and NAT10 in mammalian development and human diseases. Pharmacology & Therapeutics. 253. 108576–108576. 48 indexed citations

Lv, Wei, et al.. (2023). Label-free chemiluminescent CRISPR/Cas12a biosensing strategy for the detection of nucleic acids and non-nucleic acids utilizing DNAzyme Supernova. Sensors and Actuators B Chemical. 402. 135143–135143. 12 indexed citations

Wang, Shanshan, Wei Lv, Tao Li, et al.. (2022). Dynamic regulation and functions of mRNA m6A modification. Cancer Cell International. 22(1). 48–48. 139 indexed citations breakdown →

Wang, Huihui, Shubing Zhang, Tao Li, et al.. (2022). MicroRNA-146a promotes proliferation, migration, and invasion of HepG2 via regulating FLAP. Cancer Cell International. 22(1). 149–149. 11 indexed citations

Lv, Wei, Tao Li, Shanshan Wang, et al.. (2021). The Application of the CRISPR/Cas9 System in the Treatment of Hepatitis B Liver Cancer. Technology in Cancer Research & Treatment. 20. 2203787094–2203787094. 4 indexed citations

Lv, Wei, et al.. (2020). Research progress of kynurenine pathway in Alzheimer's disease. SHILAP Revista de lepidopterología. 1 indexed citations

Lv, Wei, Guangming Zhang, Cyril Bařinka, James H. Eubanks, & Alan P. Kozikowski. (2017). Design and Synthesis of Mercaptoacetamides as Potent, Selective, and Brain Permeable Histone Deacetylase 6 Inhibitors. ACS Medicinal Chemistry Letters. 8(5). 510–515. 35 indexed citations

Budke, Brian, Wei Lv, Alan P. Kozikowski, & Philip P. Connell. (2016). Recent Developments Using Small Molecules to Target RAD51: How to Best Modulate RAD51 for Anticancer Therapy?. ChemMedChem. 11(22). 2468–2473. 35 indexed citations

10.

Lv, Wei, Brian Budke, Michał Pawłowski, Philip P. Connell, & Alan P. Kozikowski. (2016). Development of Small Molecules that Specifically Inhibit the D-loop Activity of RAD51. Journal of Medicinal Chemistry. 59(10). 4511–4525. 46 indexed citations

11.

Lv, Wei, Brian Budke, Alan P. Kozikowski, & Philip P. Connell. (2016). Development of Small Molecules that Specifically Inhibit the D-loop Activity of RAD51. International Journal of Radiation Oncology*Biology*Physics. 96(2). S16–S17. 2 indexed citations

12.

Cheng, Jianjun, Philippe Giguère, Wei Lv, Bryan L. Roth, & Alan P. Kozikowski. (2015). Design and synthesis of (2-(5-chloro-2,2-dimethyl-2,3-dihydrobenzofuran-7-yl)cyclopropyl)methanamine as a selective serotonin 2C agonist. Tetrahedron Letters. 56(23). 3420–3422. 14 indexed citations

13.

Cheng, Jianjun, Philippe Giguère, Oluseye K. Onajole, et al.. (2015). Optimization of 2-Phenylcyclopropylmethylamines as Selective Serotonin 2C Receptor Agonists and Their Evaluation as Potential Antipsychotic Agents. Journal of Medicinal Chemistry. 58(4). 1992–2002. 31 indexed citations

14.

Lü, Kui, et al.. (2014). The Synthesis of l-dopa-l-Tyr and The Interaction of l-dopa-l-Tyr With ctDNA. International Journal of Peptide Research and Therapeutics. 20(3). 299–305. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact